Differential regulation of brain and plasma TNFalpha produced after endotoxin shock.
From undetectable basal levels, TNFalpha is produced in the hypothalamus of rats challenged with a systemic low profile endotoxin (LPS) at least 30 min before its release may be detected in the plasma. The cytotoxic activity of this hypothalamic TNFalpha correlates with its immunoreactivity. Injection of BB-1101, a matrix metalloprotease inhibitor, immediately after the LPS totally inhibits the plasma LPS-induced TNFalpha release without affecting the hypothalamic TNFalpha response. Likewise, L-NAME pretreatment, a nitric oxide inhibitor which reportedly crosses the blood-brain barrier, blunts the plasma TNFalpha response by almost 66%, but leaves the hypothalamic TNFalpha response unchanged. The present study thus describes the early occurrence of hypothalamic TNFalpha in response to systemic LPS injection, which is not subjected to the same regulations as plasma TNFalpha.
Sacoccio
C
C
CNRS ERS 5644, Université de Montpellier 2, France.
Dornand
J
J
Barbanel
G
G
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004797:Enzyme-Linked Immunosorbent Assay; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D051381:Rats; D017207:Rats, Sprague-Dawley; D012772:Shock, Septic / Q000097:blood / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D004791:Enzyme Inhibitors; D014409:Tumor Necrosis Factor-alpha; D019001:Nitric Oxide Synthase; D008666:Metalloendopeptidases